MRVI FY 2021 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$999M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$799M+181.3% YoY

Gross Profit

$659M82.4% margin

Operating Income

$555M69.4% margin

Net Income

$182M22.8% margin

EPS (Diluted)

$1.56

Cash Flow

Operating Cash Flow

$369M

Free Cash Flow

$354M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$1.4B

Stockholders' Equity

$315M

Cash & Equivalents

$551M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$799M	$284M	+181.3%
Gross Profit	$659M	$204M	+222.2%
Operating Income	$555M	$120M	+362.6%
Net Income	$182M	$77M	+136.8%